TTA-A2, CAS [[953778-63-7]]

Produktübersicht

• Artikelname: TTA-A2, CAS [[953778-63-7]]
• Artikelnummer: MCE-HY-111828
• Hersteller Artikelnummer: HY-111828
• Alternativnummer: MCE-HY-111828-5MG,MCE-HY-111828-1MG,MCE-HY-111828-50MG,MCE-HY-111828-10MG,MCE-HY-111828-10MMX1ML,MCE-HY-111828-100MG,MCE-HY-111828-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

TTA-A2 is a potent, selective and orally active t-type voltage gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation. TTA-A2 is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels with IC50 values of 89 nM and 92 nM, respectively, at -80 and -100 mV holding potentials. TTA-A2 can be used for the research of a variety of human neurological diseases, including sleep disorders and epilepsy[1][2].

Produkteigenschaften

• Molekulargewicht: 378.39
• Reinheit: 99.33
• CAS Nummer: [953778-63-7]
• Formel: C20H21F3N2O2
• Target-Kategorie: Calcium Channel

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound